key: cord-0285606-34mjuq25
authors: Kedia-Mehta, Nidhi; Pisarska, Marta M.; Rollings, Christina; O’Neill, Chloe; Barra, Conor De; Foley, Cathriona; Wood, Nicole AW.; Wrigley-Kelly, Neil; Veerapen, Natacha; Besra, Gurdyal; Bergin, Ronan; Jones, Nicholas; O’Shea, Donal; Sinclair, Linda V.; Hogan, Andrew E.
title: Human Mucosal Associated Invariant T cell proliferation is dependent on a MYC-SLC7A5-Glycolysis metabolic axis
date: 2022-01-17
journal: bioRxiv
DOI: 10.1101/2022.01.17.476571
sha: 09d847dcb3163d9179931cf0ea8df2141b8fd2d0
doc_id: 285606
cord_uid: 34mjuq25

Mucosal Associated Invariant T (MAIT) cells are an abundant population of innate T cells which recognise bacterial ligands presented by the MHC class-I like molecule MR1. MAIT cells play a key role in host protection against bacterial and viral pathogens. Upon activation MAIT cells undergo proliferative expansion and increased production of effector molecules such as cytokines. The molecular and metabolic mechanisms controlling MAIT cell effector functions are still emerging. In this study, we found that expression of the key metabolism regulator and transcription factor MYC is upregulated in MAIT cells upon immune stimulation. Using quantitative mass spectrometry, we identified the activation of two MYC controlled metabolic pathways; amino acid transport and glycolysis, both of which are critical for MAIT cell proliferation. Finally, we show that MYC expression in response to immune activation is diminished in MAIT cells isolated from people with obesity, resulting in defective MAIT cell proliferation and functional responses. Collectively our data details for the first time the importance of MYC regulated metabolism for MAIT cell proliferation, and provides additional insight into the molecular defects underpinning functional failings of MAIT cells in obesity. Graphical Abstract

MAIT cells are a population of non-MHC restricted T cells that are important in the 64 master regulator 18, 19, 21 . Experiments using high-dimensional quantitative mass 254 spectrometry on CD4 and CD8 T cells from wild type and MYC deficient mice revealed 255 how MYC controls TCR driven cell growth and metabolism 18, 19 . We show for the first 256 time that MYC is a critical regulator of MAIT cell proliferation. MAIT cell proliferation 257 was triggered in a two-step process, activation with the cognate MAIT cell antigen 5-258 ARU did not drive MAIT cell proliferation, but did trigger the expression of the high 259 affinity IL-2 receptor CD25. IL-2 is well established as a potent driver of T cell 260 proliferation, including MAIT cells 16 , and here we confirm these observations, with the 261 addition of IL-2 resulting in robust proliferation of MAIT cells. A similar two-step 262 process has previously been reported in conventional CD8 T cells, with IL-2 not 263 required for the initiation of proliferation but critical for sustaining proliferation 35 . We 264 also demonstrate that increased expression of CD25 by activated MAIT cells was 265 dependent on MYC, which aligns with previously published data which showed that in 266 MYC deficient conventional T cells, the expression of CD25 was not increased upon 267 stimulation 19 . 268 269 MYC signalling is also essential for the upregulation of amino acid transporters on T 270 cells including the most abundantly expressed SLC7A5 19 . We have previously reported 271 that MAIT cells express SLC7A5 22 , and demonstrate here that inhibition of MYC results 272 in diminished SLC7A5 and CD98 expression. Amino acid transport via SLC7A5/CD98 is 273 critical for sustained expression of MYC, suggesting a positive feed-forward loop 19 . 274

Using the SLC7A5 inhibitor BCH we show that amino acid transport through SLC7A5 is 275 critical for MAIT cell proliferation, highlighting for the first time a MYC-SLC7A5 axis in 276 activated MAIT cells. 277 278 MYC also directs a glycolytic metabolism programme in conventional T cells 18, 19, 21 , 279 which is well established as a critical process for immune growth, activation and 280 effector functions 36 . We and others have previously reported that glycolytic 281 metabolism is critical for MAIT cell cytokine and lytic molecule production 22, 27, 37 Cell populations were acquired using a Attune NXT flow cytometer and analysed using 329 were stimulated for 18 hours with anti-CD3/CD28 Dynabeads (Thermofisher), IL-12 344 (50ng/ml) and IL-18 (50ng/ml) for 18 hours. Cell pellets were lysed at room 345 temperature in 4% SDS, 50mM TEAB pH8.5, 10mM TCEP under agitation for 5 mins, the boiled for 5 mins and sonicated with a BioRuptor (30 seconds on, 30 seconds off x 347 30 cycles). Protein concentration was determined using EZQ protein quantification kit 348 (Invitrogen) according to the manufacturer's protocol. Lysates were alkylated with 349 20mM iodoacetamide for 1 hours at room temperature in the dark. The samples were 350 then processed using S-Trap mini columns (Protifi). 12% aqueous phosphoric acid was 351 added at 1:10 to each sample for a final concentration of ~1.2% phosphoric acid. 352

Samples were transferred to 5ml lo bind Eppendorf tubes (Eppendorf). 3200μl of S-353

Trap binding buffer (100mM TEAB -pH 7.1 adjusted using phosphoric acid, 90% 354

MeOH) was added to each sample. 650μl of each sample was loaded onto an S-Trap 355 column and spun at 4,000 g for 30 s or until all SDS lysate/S-Trap buffer had passed 356 through the S-Trap column. Loading and spinning of columns was repeated until all 357 the lysate was run through the column. Columns were transferred to fresh 2ml 358 collection tubes. 125μl of digestion buffer (50mM ammonium bicarbonate in HPLC 359 water) containing 1:20 trypsin was added onto each column. Samples were spun at 360 4000g for 30 seconds and any solution that passed through was returned to the top 361 of the column. Tubes were incubated for 2 hrs at 47°C. 80μL of digestion buffer 362 containing trypsin was added to each column. Samples were centrifuged at 1,000 g 363 for 60 sec and the peptide elution kept. 80μL of 0.2% aqueous formic acid was added 364 to the S-Trap protein-trapping matrix and spin through at 1,000 g for 60 sec into the 365 same collection tube. 80μL of 50% aqueous acetonitrile containing 0.2% formic acid 366 was added and samples spun at 4000g for 60 seconds for a final elution. 367 368 Data independent acquisition (DIA) mass spectrometry acquisition. An equivalent of 369 1.5µg peptides were injected onto a nanoscale C18 reverse-phase chromatography 370 column coupled to an UltiMate 3000 RSLC nano, HPLC system (Thermo Fisher) and an 371

Orbitrap Exploris 480 Mass Spectrometer (Thermo Fisher). For liquid chromatography 372 the following buffers were used: buffer A (0.1% formic acid in Milli-Q water (v/v)) and 373 buffer B (80% acetonitrile and 0.1% formic acid in Milli-Q water (v/v). Samples were 374 loaded at 10μL/min onto a trap column (100 μm × 2 cm, PepMap nanoViper C18 375 column, 5μm, 100 Å, Thermo Scientific) equilibrated in 0.1% trifluoroacetic acid (TFA). 376

The trap column was washed for 3 min at the same flow rate with 0.1% TFA then 377 switched in-line with a Thermo Scientific, resolving C18 column (75 μm × 50 cm, 378

PepMap RSLC C18 column, 2 μm, 100 Å). Peptides were eluted from the column at a 379 constant flow rate of 300nl/min with a linear gradient from 3% buffer B to 6% buffer 380 B in 5 min, then from 6% buffer B to 35% buffer B in 115 min, and finally to 80% buffer 381 B within 7 min. The column was then washed with 80% buffer B for 4 min and re-382 equilibrated in 3% buffer B for 15 min. Two blanks were run between each sample to 383 reduce carry-over. The column was kept at a constant temperature of 50°C. 384

The data was acquired using an easy spray source operated in positive mode with 385 spray voltage at 2.6 kV, and the ion transfer tube temperature at 250°C. The MS was 386 operated in DIA mode. A scan cycle comprised a full MS scan (m/z range from 350-387 1650), with RF lens at 40%, AGC target set to custom, normalised AGC target at 300%, 388 maximum injection time mode set to custom, maximum injection time at 20 ms, 389 microscan set to 1 and source fragmentation disabled. MS survey scan was followed 390 by MS/MS DIA scan events using the following parameters: multiplex ions set to false, 391 collision energy mode set to stepped, collision energy type set to normalized, HCD 392 collision energies set to 25.5, 27 and 30%, orbitrap resolution 30000, first mass 200, 393 RF lens 40%, AGC target set to custom, normalized AGC target 3000%, microscan set (directDIA) mode. Minimum peptide length was set to 7 and maximum passport 400 length was set to 52, with a maximum of 2 missed cleavages. MS1 and MS2 mass 401 tolerance strategy and XIC IM and RT extraction windows were set to dynamic, all with 402 a correction factor of 1. Trypsin was specified as the digestive enzyme used. The false 403 discovery rate at the precursor ion level and protein level was set at 1% (protein and 404

precursor Q-value cut-off). The max number of variable modifications was set to 5, 405 with protein N-terminal acetylation, methionine oxidation and glutamine and 406 asparagine deamidation set as variable modifications. Carbamidomethylation of 407 cysteine residues was selected as a fixed modification. For calibration, the MS1 and 408 MS2 mass tolerance strategy was set to the system default. Machine learning was set 409 to across experiment, with a precursor PEP cut-off of 1, a protein Q-value cut-off of 410 0.01. Single-hit proteins were not excluded, with single-hits defined by stripped 411 sequence. For quantification, amino acids were set to false and best N fragments per 412 peptide was set to true, with a minimum of 3 and maximum of 300, and ion charge 413 and type set to false. The major protein grouping was by protein group ID and the 414 minor peptide grouping was set to stripped sequence. Modifications were set to none 415

Major and minor group top N was set to false, with minor and major group quantities 416 set to sum precursor quantity and sum peptide quantity respectively. Quantity at the 417 MS-level was set to MS2 and quantity type to area. Proteotypicity filter was set to 418 none, data filtering to Q-value and cross run normalisation was switched off. MS2 419 demultiplexing was disabled, the run limit for the directDIA library set to -1, with no 420 profiling strategy or unify peptide peaks strategy. Data filtering and protein copy 421 number quantification was performed in the Perseus software package, version 422 1.6.6.0. Proteins were quantified from unique peptides and razor peptides. Copy 423 numbers were calculated using the proteomic ruler as described (Wisniewski et al., 424 2014) . This method sets the summed peptide intensities of the histones to the 425 number of histones in a typical diploid mouse cell. The ratio between the histone 426 peptide intensity and summed peptide intensities of all other identified proteins is 427 then used to estimate the protein copy number per cell for all the identified proteins. 428

Further filtration of the data was completed to include proteins detected in at least ≥ 429 2 biological replicates. 430

Cell trace violet proliferation assay. MAIT cell proliferation was also measured using 431 a CellTrace TM Violet (CTV) proliferation kit (ThermoFisher) according to the 432 manufacturer's instructions. Briefly, CellTrace solution was prepared immediately 433 prior to use to 5mM stock using DMSO. Next the dye for diluted to 5μM working 434 concentration by adding appropriate amount of the stock solution into pre-warmed 435 PBS. Isolated PBMC were stained at 10 6 cells per mL of the PBS-dye solution. Cells 436 were incubated for 20 min at room temperature, protected from light with circular agitation. Unbound dye was washed away with RPMI, and cell were incubated for at 438 least 10 minutes to allow acetate hydrolysis of the dye. CTV stained cells were 439 stimulated for 18 hours with 1µg/mL of 5-ARU and 100µM of methylglyoxal, in the 440 absence or presence of specific metabolic inhibitors (2DG (2mM), 10074-G5(10uM), 441 iBET762(10µM) or BCH (50mM)). After 18 hours, media was replaced with fresh 442 culture media containing IL-2 (35ng/ml). Cultures were maintained for 5 days before Data is expressed as SEM. We determined differences between two groups using 499 student t-test and Mann Whitney U test where appropriate. Analysis across 3 or more 500 groups was performed using ANOVA. Correlations were determined using linear 501 regression models and expressed using Pearson or Spearman's rank correlation 502 coefficient, as appropriate. P values were expressed with significance set at <0.05. 

A "proteomic ruler" for 590 protein copy number and concentration estimation without spike

Quantitative analysis of T cell proteomes and 594 environmental sensors during T cell differentiation

The cytotoxic T cell proteome and its shaping by the 598 kinase mTOR

Differential regulation of T-cell 601 growth by IL-2 and IL-15

Targeting mitochondrial dysfunction in MAIT cells limits IL-604 17 production in obesity

Mucosal-associated invariant T cell alterations in obese and 607 type 2 diabetic patients

MAIT Cells in Health and Disease

Mucosal-associated invariant 613 T cells and disease

Mucosal Associated 616 Invariant T Cells in Cancer-Friend or Foe?

Unconventional T Cell Targets for Cancer Immunotherapy

A Multi-Omics Analysis of Mucosal-Associated-Invariant T 623 Cells Reveals Key Drivers of Distinct Modes of Activation

Proteomic definition of human mucosal-associated invariant 627 T cells determines their unique molecular effector phenotype

IL-2 is not required for the initiation of CD8 T 631 cell cycling but sustains expansion

A guide to immunometabolism for 634 immunologists

Human MAIT cells show metabolic quiescence with rapid 637 glucose-dependent upregulation of granzyme B upon stimulation

Divergent 641 Impact of Glucose Availability on Human Virus-Specific and Generically 642 Activated CD8 T Cells

COVID-19 severity and obesity: are MAIT cells a factor?

Metabolic reprogramming of natural killer cells in obesity 652 limits antitumor responses

NK cells in childhood obesity are activated, metabolically 655 stressed, and functionally deficient

658 InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams

Proteins from IL-2 665 expanded MAIT (MAIT IL-2 ) cells were ranked by mass contribution and the mean 666 cumulative protein mass was plotted against protein rank. (B) Table outlining the total 667 number of proteins detected in MAIT IL-2 cells and their change upon stimulation 668 (MAIT STIM ; 18 hours with antiCD3/CD28 beads and 50ng/ml IL-12 & IL-18) using 669 quantitative proteomics

Scatter plot showing ex-vivo MAIT cell size (Forward scatter) basally or stimulated (as 671 above). (E) Heatmap of the proteome of MAIT IL-2 and MAIT STIM cells

Relative protein abundance is graded from blue (low) to red (high) per row. Key MAIT 673 cell proteins (IL-18R1, KLRB1, DPPIV & TRAV1-2) are represented in scatter graphs and 674 their position in the heatmap is denoted by arrows). (F) Volcano plot displaying the 675

MAIT STIM cell proteome compared with MAIT IL-2 (Green circles represent proteins 676 increased more than 1.5 fold over MAIT IL-2 cells, and grey dots represent proteins 677 decreased more than 1.5 fold). (G) Pie chart proportional pathway analysis based on 678 the MAIT STIM cell proteome

GSEA plot 681 showing the increase in MYC target gene expression in activated MAIT cells. Data 682 extrapolated from RNA sequence dataset published by Lamichhane et al on ex vivo 683 MAIT cells stimulated via TCR. (B) Heatmap displaying expression levels of MYC and 684 MYC-target in basal (MAIT IL-2 ) or stimulated (MAIT STIM

Relative protein abundance is graded from grey (low) to green (high) per row

D-E) Western blot and densitometry displaying MYC expression in MAIT IL-2 or 689 stimulated (as above) MAIT STIM cells. (F-G) Representative flow cytometry histogram 690 (F) (Mean Fluorescence Intensity (MFI) values are shown within histogram) and MFI 691 values (G) of MYC expression in ex vivo MAIT cells (black) or stimulated with 18hr 692 antiCD3/CD28 beads + 50ng/ml IL-18 (green). (H) Heatmap displaying MYC target 693 genes in ex vivo MAIT cells with or without TCR stimulation. Data extrapolated from 694 RNA sequence dataset published by Hinks

IL-2RA) expression on MAIT ex vivo or stimulated through the TCR using antiCD3/CD28 701 beads/IL-12 & IL18 (MAIT STIM ) for 18 hours (n=9). (D) Scatter plot showing CD25 (IL-702 2RA) protein copies in MAIT IL-2 cells basally or stimulated through the TCR using 703 antiCD3/CD28 beads/IL-12 & IL18 (MAIT STIM ) (n=4). (E) Line graph demonstrating 704 frequency of MAIT cells (represented as percentage of T cells) after stimulation with 705 5-ARU (1ug/ml) and Methylglyoxal (100µM) in the absence or presence of IL-2 706 (35ng/ml) for 7 days (n=5). (F-G) Representative flow cytometry dot plot and scatter 707 plot showing MAIT cell frequencies after 7 days stimulation with 5-ARU, Methylglyoxal 708 and IL-2 (n=10). (H) MFI of CD25 expression on MAIT cells after 18 hours stimulation 709 (as in C) in the absence or presence of the MYC specific inhibitor (10074-G5, 10uM) 710 (n=5). (I) MAIT IL-2 cell frequency after 7 days expansion (as in E) in the absence of 711 presence of the MYC specific inhibitor 10074-G5 (10uM). (J) Forward scatter MFI of 712 MAIT cells after stimulation

Figure 4. SLC7A5 facilitates MAIT cell proliferation and is dependent on MYC

Mean protein copy number per cell of SLC7A5 in MAIT IL-2 cells and in cells stimulated 718 for 18hrs (MAIT STIM ; antiCD3/CD28 beads/IL-12 & IL18) (n=4). (B) Scatter plot showing 719 SLC7A5 mRNA expression in MAIT IL-2 cells or MAIT STIM (as in A) (n=12)

Flow cytometry data of uptake of kynurenine into ex vivo MAIT cells 722 (n=5). (E) SLC7A5 mRNA expression in MAIT IL-2 cells and MAIT STIM (as in A) in the 723 absence or presence of the MYC specific inhibitor 10074-G5. (F) Flow cytometry MFI 724 expression of CD98 on ex-vivo MAIT cells after stimulation (as in A) in the absence or 725 presence of the MYC specific inhibitor 10074-G5 (10uM) (n=5). (G) The frequency of 726 MAIT cells after 7 days expansion with 5-ARU (1ug/ml) and Methylglyoxal (100µM) in 727 the absence or presence of IL-2 (35ng/ml)) in the absence of presence of the SLC7A5 728 inhibitor BCH (n=5). (H-I) Representative flow cytometry histogram and scatter plot 729 showing cell trace violet (CTV) MFI in MAIT cells after 5 days stimulation

Glucose metabolism facilitates MAIT cell proliferation and is dependent on 733 MYC. (A) Mean protein copy number per cell of Hexokinase-II (HKII) in MAIT IL-2 and in 734

(n=4). (B-C) Representative flow cytometry histogram and MFI data of HKII in MAIT ex-736 vivo cells basally or stimulated

MAIT STIM )(n=8). (D) Flow cytometry MFI data of LDHA expression in MAIT ex-vivo and 738

MAIT STIM cells (as in C) (n=8). (E) HKII mRNA expression in MAIT IL-2 and in and in 739

n=5). (F) The frequency of MAIT cells after 7 days expansion from PBMC 741 (1x10 6 ) using cognate antigen 5-ARU (1ug/ml), Methylglyoxal (100µM) and IL-2 742 (35ng/ml

CTV) MFI in MAIT cells after 5 days stimulation (as in F) in the absence of presence of 745 2DG (n=5). (I-J) Representative flow cytometry dot plot (I) and MAIT cell frequencies 746 (J) after 7 days stimulation (as in F) in media containing either 10mM or 1mM glucose 747 (n=3). (K-L) Representative flow cytometry dot plot (K) and MAIT cell frequencies (L) 748 after 7 days stimulation (as in F) in media containing either 10mM glucose or 10mM 749 galactose (n=6)

Methylglyoxal (100µM) and maintenance in IL-2 (35ng/ml) in 755 either healthy controls (green circles) or people with obesity (PWO) (grey circles) 756 (n=10/group). (B) Fold expansion of MAIT cells from healthy controls or people with 757 obesity after 7 days stimulation (with 5-ARU (1ug/ml), Methylglyoxal (100µM) and IL-758 2 (35ng/ml)) (n=8). (C-D) Representative flow cytometry histogram (C) and MFI data 759 (D) of MYC expression in ex vivo MAIT cells from healthy controls (top panel,C) or PWO 760 (bottom panel,C) stimulated with antiCD3/CD28 beads and IL-18 (50ng/ml) for 18 761 hours (n=6-7/group). (E) Heatmap displaying MYC target genes in ex-vivo MAIT cells 762 from health controls or PWO (n=4-5/group). (F) CD25 expression (MFI) on ex-vivo 763 MAIT cells or stimulated MAIT cells (as in C) from either healthy controls or PWO

Scatter plot showing CD98 766 expression (MFI) on ex-vivo MAIT cells basally or stimulated (as in C) from either 767 healthy controls or PWO (n=3-4/group). (I) Scatter plot showing Kynurenine uptake 768 into MAIT cells from either healthy controls or PWO (n=5/group)

Supplementary Figure 1. In silico transcriptomic analysis highlights upregulation of 773 MYC target genes. (A) In silico transcriptomic analysis highlights the enrichment of 774 common Gene Sets within differentially stimulated MAIT cells. (A) In silico analysis of 775 data extrapolated from an RNA sequencing dataset published by Lamichhane et al

Venn Diagram displays the number of significantly upregulated Hallmark Gene Sets 778 following Gene Set Enrichment Analysis for each stimulation. (B) Heatmap of data 779 from (A) displaying expression levels of significantly (FDR <0.1) differentially 780 expressed MYC-target genes in unstimulated or TCR stimulated MAIT cells 781

M 66.6 G.